Clinical trials
Patient clinical trials
Below are recruiting patient clinical trials, each written for real people, not researchers. We’re tracking 14,814 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05009758Recruiting
Asthma and nasal polyps study to match immune patterns
This study looks at different “immune inflammation patterns” in people with asthma and/or nasal polyps. It may help researchers better tailor future treatments by figuring out which patterns go with which symptoms.
ViennaAges 18–99 - NCT05029531RecruitingPhase 3
Immuno-chemotherapy for infants with B-lineage ALL
This trial tests a combination of medicines (immunotherapy plus chemotherapy) in babies diagnosed with a type of leukemia called B-lineage acute lymphoblastic leukemia (ALL). It aims to improve how well treatment works and is delivered safely in very young children.
Moscow, Samory-Mashela,1Ages 1 day–12 months - NCT05121012Recruiting
PET brain scan study for synaptic loss in MSA or PSP
This study uses brain scans (PET, and possibly spinal fluid) to measure changes linked to “synaptic loss” in people with multiple system atrophy (MSA) or progressive supranuclear palsy (PSP). It may help researchers understand disease changes and how they relate to symptoms, which could guide future treatments.
ExeterAges 45–80 - NCT05127148Recruiting
Real-world study of pediatric-like treatment for Ph-negative ALL
This study follows how well a “pediatric-style” treatment plan works in teens and young adults with Ph-negative acute lymphoblastic leukemia (ALL) in real-world care. It mainly aims to understand outcomes and safety for patients who fit the specific leukemia and health criteria.
Paraná, Entre Ríos ProvinceAges 18–40 - NCT05150249Recruiting
Study of older adults after hip fracture treated in hospitals
This is an observational study that follows people age 65 and older after a hip (femur) fracture to learn about their care and outcomes in participating hospitals. It won’t test a new treatment, but your participation may help improve future care for older patients.
BaggiovaraAges 65 years+ - NCT05157113RecruitingPhase 4
After cataract surgery, a drop-free medicine plan
This trial studies whether a “drop-free” medication plan after cataract surgery works well and is practical for people receiving care at a county hospital. It may help reduce the need for multiple eye drops after surgery while still protecting the eye as it heals.
San Francisco, CaliforniaAges 18 years+ - NCT05216432RecruitingPhase 1
RLY-2608 for PIK3CA-mutant advanced solid tumors and breast cancer
This early study (Phase 1) tests RLY-2608, a targeted cancer drug for tumors with a PIK3CA mutation. It studies the drug alone and combined with hormone therapy (and sometimes CDK4/6 or CDK4 medicines) to see safety, dose, and whether it can shrink tumors.
Tucson, ArizonaAges 18 years+ - NCT05319483Recruiting
Study of new head and neck cancer patients
This study enrolls adults with a first-time head and neck cancer diagnosis and collects health and treatment information to better understand the disease. It may help clinicians improve care by learning which treatments and patient features matter most.
Pécs, BaranyaAges Any age - NCT05346510Recruiting
Prone CT and ultrasound to check underarm lymph nodes
This study checks how well CT scans and ultrasound (done while lying face-down) can identify underarm lymph node involvement in people with breast cancer before surgery. If accurate, this may help guide whether additional lymph node surgery is needed.
Shenyang, LiaoningAges 18–70 - NCT05364606Recruiting
Patient-specific ankle spacer for avascular necrosis after surgery
This study follows people who are getting a custom-made spacer implanted in the ankle for avascular necrosis. It’s mainly checking what happens after the surgery in real-world care, and it may help improve how these implants are used and tracked over time.
Santa Rosa, CaliforniaAges 21 years+ - NCT05393791RecruitingPhase 2
Personalized abiraterone or enzalutamide plan for advanced prostate cancer
This trial compares a personalized (adaptive) treatment plan versus a steady (continuous) plan using either abiraterone or enzalutamide (with the same standard hormone-suppression). It aims to see which approach controls advanced metastatic prostate cancer better while keeping side effects manageable.
Albury, New South WalesAges 18 years+ - NCT05407129Recruiting
Improve hospital safety by sharing your recent experience
This trial asks patients, families, caregivers, and hospital staff to report what happened during a recent hospital stay to help improve safety. Your feedback may help the hospital change processes that prevent problems for others.
Boston, MassachusettsAges Any age - NCT05410275RecruitingPhase 3
Low-dose rivaroxaban for dialysis patients without blood thinners
This study tests whether a lower dose of the blood thinner rivaroxaban is safe for people with kidney failure on dialysis who do not already need blood thinners. The goal is to find a way to prevent blood clots and strokes with less risk of bleeding.
ToursAges 18 years+ - NCT05452356Recruiting
Testing a phone-based care plan for people with heart conditions
This trial tests a phone app that helps deliver organized “care plans” for people with cardiovascular (heart/vessel) conditions. You might join to see if this phone-based support improves how care is delivered and helps you manage your condition.
London, OntarioAges 18 years+ - NCT05487846Recruiting
Peer support during genetic testing for metastatic prostate cancer
This trial offers support from a trained peer to help African American men understand and go through genetic testing for prostate cancer. It may help you feel less overwhelmed and better prepared during the testing and decision-making process.
Philadelphia, PennsylvaniaAges 18 years+ - NCT05500118Recruiting
Decision help tool for symptom-free fibroids treated with HIFU
This study is testing a decision-making tool to help doctors choose the best care for women with small fibroids that cause no symptoms. It also looks at factors that may affect outcomes when using HIFU, a non-surgical treatment that heats tissue with focused ultrasound.
Shenzhen, GuangdongAges 18–55 - NCT05500001Recruiting
Family education after a recent psychosis hospital visit
This study follows young people after a recent hospital stay or discharge for psychosis to see how family education affects outcomes. You may benefit from extra support and structured teaching for both you and your family.
Edmonton, AlbertaAges 17–27 - NCT05504265RecruitingPhase 2/Phase 3
Pain control methods during minimally invasive esophagus surgery
This study compares different ways to control pain around the time of minimally invasive esophagus surgery. It may help find a method that controls pain better and improves recovery after surgery.
BeijingAges 18–75 - NCT05522647Recruiting
Study of risk behaviors in hospitalized confused or agitated patients
This is a study that observes how often and what kinds of “risk behaviors” happen in neurosurgery patients who are agitated or confused. It aims to better understand these behaviors so care can be improved for people who are unable to move or who seem restless.
Clermont-FerrandAges 18 years+ - NCT05544084Recruiting
Patient navigation program for cervical screening in Senegal
This study tests a patient “navigator” approach to improve cervical cancer screening and prevention access in Senegal. You may be invited to help through community education, health facility work, or by being part of a screening-support household.
DakarAges 25–69 - NCT05554003RecruitingPhase 2
Low-grade neuroendocrine tumors: metronomic temozolomide for frail patients
This Phase 2 study tests a gentler, steady schedule of temozolomide in people with advanced low-grade neuroendocrine neoplasms who are “unfit” for stronger treatments. The goal is to shrink or control the cancer while being safer for people with weaker health or organ function.
MilanAges 18 years+ - NCT05562258Recruiting
Peer coaching for teens with eating disorders
This study tests a “peer-coaching” program where a teen receives support from someone with lived experience, alongside their care. It may help improve how teens manage their eating disorder treatment and feel supported during recovery.
New York, New YorkAges 12–18 - NCT05582551Recruiting
Screening test program for childhood cancer survivor senses
This trial helps improve how doctors check senses like hearing and vision after childhood cancer. It may help you (or your child) get better screening and support early for new or lasting side effects.
St Louis, MissouriAges 7–17 - NCT05588856Recruiting
Improving medical advice through better doctor–patient partnerships
This study looks at whether improving communication between doctors and patients leads to better medical advice for people with chronic lung disease. If you have a confirmed diagnosis and can consent, you may be invited to take part.
SingaporeAges 21–99
Hear when a new Patient trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient?
- Yes. Clin2 currently lists 14,814 recruiting patient studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.